Literature DB >> 3392560

Estrogen receptor versus nuclear grade as prognostic factors in axillary node negative breast cancer.

W L McGuire.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392560     DOI: 10.1200/JCO.1988.6.7.1071

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Prognostic factors and natural history in lymph node-negative breast cancer patients.

Authors:  R Arriagada; L E Rutqvist; L Skoog; H Johansson; A Kramar
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 2.  Systemic adjuvant therapy for node-negative breast cancer.

Authors:  A D Ginsburg; D J Perrault; K I Pritchard; G P Browman; P B McCulloch; J Skillings
Journal:  CMAJ       Date:  1989-09-01       Impact factor: 8.262

3.  Nuclear characteristics as indicators of prognosis in node negative breast cancer patients.

Authors:  V le Doussal; M Tubiana-Hulin; K Hacene; S Friedman; M Brunet
Journal:  Breast Cancer Res Treat       Date:  1989-11       Impact factor: 4.872

Review 4.  Response to treatment of breast cancer.

Authors:  J L Berenberg
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

5.  Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.

Authors:  M A Levesque; E P Diamandis; H Yu; D J Sutherland
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.